ArticleTranslational cancer research2026

Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids.

Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.